Oncolytics Biotech, Inc.
ONCY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.69M
Close$
$0.05
88.1% downside
Current Fair Value
88.1% downsideOvervalued by 88.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $42.69 Million |
|---|---|
| Enterprise Value | $39.03 Million |
| Earnings per Share | $-0.41 |
| Beta | 1.16 |
| Outstanding Shares | 119,739,942 |
Return
| Return on Equity | 560.92% |
|---|---|
| Return on Assets | -450.95% |
| Return on Invested Capital | -1420.73% |
Valuation & Multiples
| P/E Ratio | -1.72 |
|---|---|
| PEG | -3.24 |
| Price to Sales | - |
| Price to Book Ratio | -0.4 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.12 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 30, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.05
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.70%▼ 2.84% |
|---|---|
| Total Invested | $381,594▼ 89.87% |
| Investors Holding | 17▼ 61.00% |